Evogene (EVGN) Shares Outstanding (2012 - 2026)

Evogene has reported Shares Outstanding (Entity) for 15 years, with the latest figure at $9.7 billion in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 43.25% year-over-year to $9.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.7 billion (up 43.25% YoY) and the FY2025 annual result came in at $8.7 million, up 33.83% from the prior year.
• Shares Outstanding (Entity) improved to $9.7 billion in Q1 2026 per EVGN's latest filing, from $8.7 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $9.7 billion in Q1 2026 and troughed at $4.1 million in Q2 2022.
• A 5-year average of $3.1 billion and a median of $4.1 billion in 2022 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) climbed 0.22% in 2022, then surged 50.1% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $4.1 million in 2022, then gained by 22.6% to $5.1 million in 2023, then gained by 28.79% to $6.5 million in 2024, then surged by 33.83% to $8.7 million in 2025, then soared by 111602.44% to $9.7 billion in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $9.7 billion, $8.7 million, and $8.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.